Chromosomal location targets different MYC family gene members for oncogenic translocations

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 7, 2009, Pages 2265-2270

  Gostissa, Monica ^a   Ranganath, Sheila ^a   Bianco, Julia M ^a   Alt, Frederick W ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b Karp Family Research Building ^*  (United States)

Author keywords

Genomic instability; Immunoglobulin genes; Nonhomologous end joining; Pro B cell lymphoma

Indexed keywords

MYC PROTEIN;

ARTICLE; CHROMOSOMAL LOCALIZATION; CONTROLLED STUDY; GENETIC ANALYSIS; HUMAN; NEUROBLASTOMA; ONCOGENE C MYC; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

ALLELES; ANIMALS; CHROMOSOME ABERRATIONS; CHROMOSOMES; DNA; DNA LIGASES; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MICE; ONCOGENES; PROTO-ONCOGENE PROTEINS C-MYC; TUMOR SUPPRESSOR PROTEIN P53;

MUS;

EID: 60549088880     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0812763106     Document Type: Article

References (39)

1. Henriksson M, Luscher B (1996) Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv Cancer Res 68:109-182.
2. Grandori C, Cowley SM, James LP, Eisenman RN (2000) The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol 16:653-699.
3. Nesbit CE, Tersak JM, Prochownik EV (1999) MYC oncogenes and human neoplastic disease. Oncogene 18:3004-3016.
4. Strieder V, Lutz W (2002) Regulation of N-myc expression in development and disease. Cancer Lett 180:107-119.
5. Vita M, Henriksson M (2006) The Myc oncoprotein as a therapeutic target for human cancer. Semin Cancer Biol 16:318-330.
6. Dang CV, et al. (1999) Function of the c-Myc oncogenic transcription factor. Exp Cell Res 253:63-77.
7. Zimmerman K, Legouy E, Stewart V, Depinho R, Alt FW (1990) Differential regulation of the N-myc gene in transfected cells and transgenic mice. Mol Cell Biol 10:2096-2103.
8. Downs KM, Martin GR, Bishop JM (1989) Contrasting patterns of myc and N-myc expression during gastrulation of the mouse embryo. Genes Dev 3:860-869.
9. Zimmerman KA, et al. (1986) Differential expression of myc family genes during murine development. Nature 319:780-783.
10. Xu L, Morgenbesser SD, DePinho RA (1991) Complex transcriptional regulation of myc family gene expression in the developing mouse brain and liver. Mol Cell Biol 11:6007-6015.
11. Mugrauer G, Alt FW, Ekblom P (1988) N-myc proto-oncogene expression during organogenesis in the developing mouse as revealed by in situ hybridization. J Cell Biol 107:1325-1335.
12. Nesbit CE, Grove LE, Yin X, Prochownik EV (1998) Differential apoptotic behaviors of c-myc, N-myc, and L-myc oncoproteins. Cell Growth Differ 9:731-741.
13. Barrett J, Birrer MJ, Kato GJ, Dosaka-Akita H, Dang CV (1992) Activation domains of L-Myc and c-Myc determine their transforming potencies in rat embryo cells. Mol Cell Biol 12:3130-3137.
14. Aubry S, Charron J (2000) N-Myc shares cellular functions wiht c-Myc. DNA Cell Biol 19:353-364.
15. Malynn BA, et al. (2000) N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation. Genes Dev 14:1390-1399.
16. Schwab M (2004) MYCN in neuronal tumours. Cancer Lett 204:179-187.
17. Kuppers R (2005) Mechanism of B-cell lymphoma pathogenesis. Nat Rev Cancer 5:251-262.
18. Kuppers R, Dalla-Favera R (2001) Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 20:5580-5594.
19. Boxer LM, Dang CV (2001) Translocations involving c-myc and c-myc function. Oncogene 20:5595-5610.
20. Jung D, Giallourakis C, Mostoslavsky R, Alt FW (2006) Mechanism and control of V(D)J recombination at the immunoglobulin heavy chain locus. Annu Rev Immunol 24:541-570.
21. Chaudhuri J, Alt FW (2004) Class-switch recombination: interplay of transcription, DNA deamination and DNA repair. Nat Rev Immunol 4:541-552.
22. Raghavan SC, Swanson PC, Wu X, Hsieh CL, Lieber MR (2004) A non-B-DNA structure at the Bcl-2 major breakpoint region is cleaved by the RAG complex. Nature 428:88-93.
23. Ramiro AR, et al. (2004) AID is required for c-myc/IgH chromosome translocations in vivo. Cell 118:431-438.
24. Gao Y, et al. (2000) Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development. Nature 404:897-900.
25. Frank KM, et al. (2000) DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathway. Mol Cell 5:993-1002.
26. Difilippantonio MJ, et al. (2002) Evidence for replicative repair of DNA double-strand breaks leading to oncogenic translocation and gene amplification. J Exp Med 196:469-480.
27. Difilippantonio MJ, et al. (2000) DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation. Nature 404:510-514.
28. Zhu C, et al. (2002) Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations. Cell 109:811-821.
29. Adams JM, et al. (1985) The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318:533-538.
30. Rosenbaum H, Webb E, Adams JM, Cory S, Harris AW (1989) N-myc transgene promotes B lymphoid proliferation, elicits lymphomas and reveals cross-regulation with c-myc. EMBO J 8:749-755.
31. Dildrop R, et al. (1989) IgH enhancer-mediated deregulation of N-myc gene expression in transgenic mice: generation of lymphoid neoplasias that lack c-myc expression. EMBO J 8:1121-1128.
32. Sheppard RD, Samant SA, Rosenberg M, Silver LM, Cole MD (1998) Transgenic N-myc mouse model for indolent B cell lymphoma: tumor characterization and analysis of genetic alterations in spontaneous and retrovirally accelerated tumors. Oncogene 17:2073-2085.
33. Rooney S, et al. (2004) Artemis and p53 cooperate to suppress oncogenic N-myc amplification in progenitor B cells. Proc Natl Acad Sci USA 101:2410-2415.
34. Frank KM, et al. (1998) Late embryonic lethality and impaired V(D)J recombination in mice lacking DNA ligase IV. Nature 396:173-177.
35. Luscher B (2001) Function and regulation of the transcription factors of the Myc/Max/Mad network. Gene 277:1-14.
36. Yan CT, et al. (2006) XRCC4 suppresses medulloblastomas with recurrent translocations in p53-deficient mice. Proc Natl Acad Sci USA 103:7378-7383.
37. Gladdy RA, et al. (2003) The RAG-1/2 endonuclease causes genomic instability and controls CNS complications of lymphoblastic leukemia in p53/Prkdc-deficient mice. Cancer Cell 3:37-50.
38. Raghavan SC, Gu J, Swanson PC, Lieber MR (2007) The structure-specific nicking of small heteroduplexes by the RAG complex: implications for lymphoid chromosomal translocations. DNA Repair (Amst) 6:751-759.
39. Franco S, et al. (2006) H2AX prevents DNA breaks from progressing to chromosome breaks and translocations. Mol Cell 21:201-214.